Search Results - "Arzneimittel-Forschung"

Refine Results
  1. 1
  2. 2

    The Preventive Oral Supplementation of a Selenium Nanoparticle-enriched Probiotic Increases the Immune Response and Lifespan of 4T1 Breast Cancer Bearing Mice by YAZDI, M. H, MAHDAVI, M, KHERADMAND, E, SHAHVERDI, A. R

    Published in Arzneimittel-Forschung (01-11-2012)
    “…The immunomodulatory effects of lactic acid bacteria have been demonstrated previously. In this study, a Lactobacillus plantarum strain was selected and…”
    Get full text
    Journal Article
  3. 3

    Interaction of CJY, an isoflavone, with ATPase of P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells by Cen, J, Liu, L, He, L, Ji, B-S

    Published in Drug research (01-08-2013)
    “…The previous study reported CJY, an isoflavone, can reverse P-glycoprotein (P-gp)-mediated multidrug-resistance (MDR) in doxorubicin-resistant human…”
    Get more information
    Journal Article
  4. 4

    Intrinsic and acquired drug resistance in malignant tumors. The main reason for therapeutic failure by Lippert, Theodor H, Ruoff, Hans-Jörg, Volm, Manfred

    Published in Arzneimittel-Forschung (2008)
    “…Drug resistance is the major reason for failure in cancer chemotherapy. Resistance may be either pre-existent (intrinsic resistance), or induced by drugs…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features : A randomised, placebo-controlled, double-blind clinical trial by NAPRYEYENKO, Oleksandr, BORZENKO, Irina

    Published in Arzneimittel-Forschung (2007)
    “…In previous trials of the Ginkgo biloba special extract EGb 761 improvements in cognitive functioning and behavioural symptoms were found in patients with…”
    Get full text
    Journal Article
  7. 7

    Development of a Subcutaneous Formulation for Trastuzumab: Nonclinical and Clinical Bridging Approach to the Approved Intravenous Dosing Regimen by BITTNER, B, RICHTER, W. F, HOURCADE-POTELLERET, F, MCLNTYRE, C, HERTING, F, ZEPEDA, M. L, SCHMIDT, J

    Published in Arzneimittel-Forschung (01-09-2012)
    “…A subcutaneous (SC) formulation has been developed for the humanized monoclonal antibody (mAb) trastuzumab as an alternative to established intravenous (IV)…”
    Get full text
    Journal Article
  8. 8

    Pharmacokinetics and Potential Advantages of a New Oral Solution of Levothyroxine vs. other Available Dosage Forms by YUE, C. S, SCARSI, C, DUCHARME, M. P

    Published in Arzneimittel-Forschung (01-12-2012)
    “…To better understand the pharmacokinetics and potential advantages of a levothyroxine oral solution vs. tablets and soft gel capsules.4 randomized,…”
    Get full text
    Journal Article
  9. 9

    Anti-nociceptive and Anti-inflammatory Effects of Cyanocobalamin (Vitamin B12) Against Acute and Chronic Pain and Inflammation in Mice by HOSSEINZADEH, H, MOALLEM, S. A, MOSHIRI, M, SARNAVAZI, M. S, ETEMAD, L

    Published in Arzneimittel-Forschung (01-07-2012)
    “…In this study, the anti-nociceptive and anti-inflammatory effects of cyanocobalamin (Vit B12) against acute and chronic pain and inflammation were evaluated in…”
    Get full text
    Journal Article
  10. 10

    Paracetamol (acetaminophen) - a popular and widely used nonopioid analgesic by Klotz, U

    Published in Arzneimittel-Forschung (01-08-2012)
    “…For several decades paracetamol has proven its clinical efficacy and safety in the treatment of various acute and chronic pain states. Whereas its…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents : A single-blind clinical investigation by CICERO, Arrigo F. G, ROVATI, Lucio C, SETNIKAR, Ivo

    Published in Arzneimittel-Forschung (2007)
    “…Berberine (BERB) and a combination (COMB) of berberine (CAS 2086-83-1) with policosanol (CAS 557-61-9), red yeast extract (containing monacolin, CAS 557-61-9),…”
    Get full text
    Journal Article
  13. 13

    The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review by Qunibi, Wajeh Y

    Published in Arzneimittel-Forschung (01-01-2010)
    “…Iron-deficiency anaemia (IDA) is a major health problem worldwide, but responds well to iron supplementation. New approaches are leading to more effective…”
    Get full text
    Journal Article
  14. 14

    The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose by Funk, Felix, Ryle, Peter, Canclini, Camillo, Neiser, Susann, Geisser, Peter

    Published in Arzneimittel-Forschung (01-01-2010)
    “…An ideal preparation for intravenous iron replacement therapy should balance effectiveness and safety. Compounds that release iron rapidly tend to cause…”
    Get full text
    Journal Article
  15. 15

    Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model by TOBLLI, Jorge E, CAO, Gabriel, OLIVERI, Leda, ANGEROSA, Margarita

    Published in Arzneimittel-Forschung (01-01-2011)
    “…Intravenous (i.v.) iron is associated with a risk of oxidative stress. The effects of ferumoxytol, a recently approved i.v. iron preparation, were compared…”
    Get full text
    Journal Article
  16. 16

    Male Reproductive Toxicity and Toxicokinetics of Triptolide in Rats by Ni, Bin, Jiang, Zhenzhou, Huang, Xin, Xu, Fengguo, Zhang, Rui, Zhang, Zunjian, Tian, Yuan, Wang, Tao, Zhu, Tian, Liu, Jing, Zhang, Luyong

    Published in Arzneimittel-Forschung (01-01-2008)
    “…As the unique quality control standard of Tabellae Glucosidorum Tripterygii Totorum, triptolide (CAS 38748-32-2) has a narrow therapeutic window. A significant…”
    Get full text
    Journal Article
  17. 17

    Protective Effect of Puerarin on β-Amyloid-Induced Neurotoxicity in Rat Hippocampal Neurons by LIN, F, XIE, B, CAI, F, WU, G

    Published in Arzneimittel-Forschung (01-04-2012)
    “…Puerarin (CAS Number 3681-99-0), a major isoflavone glycoside purified from Pueraria lobata, was reported to possess antioxidative and estrogen-like biological…”
    Get full text
    Journal Article
  18. 18

    Dapson in Heterocyclic Chemistry Part VI: Synthesis and Molecular Docking of Some Novel Sulfonebiscompounds of Expected Anticancer Activity by CHORAB, M. M, AL-SAID, M. S, NISSAN, Y. M

    Published in Arzneimittel-Forschung (01-11-2012)
    “…To discover new bioactive lead compounds for medicinal purposes, herein, sulfone biscompounds bearing dihydrothiazoles (3-9, 14, 15), acrylamide (11),…”
    Get full text
    Journal Article
  19. 19

    Antioxidative and Lipid Lowering Effects of 7,8-Dihydroxy-3-(4-methylphenyl) Coumarin in Hyperlipidemic Rats by YUCE, Basak, DANIS, Ozkan, OGAN, Ayse, SENER, Goksel, BULUT, Mustafa, YARAT, Aysen

    Published in Arzneimittel-Forschung (01-01-2009)
    “…In this study, 7,8-dihydroxy-3-(4-methylphenyl) coumarin (DHMPC), a new coumarin derivative, was tested for the first time to determine whether it had any…”
    Get full text
    Journal Article
  20. 20

    Synthesis and anticonvulsant activity of new kojic acid derivatives by AYTEMIR, Mutlu Dilsiz, SEPTIOGLU, Ebubekir, CALIS, Ünsal

    Published in Arzneimittel-Forschung (01-01-2010)
    “…A series of new 3-hydroxy-6-hydroxymethyl-2-substituted 4H-pyran-4-one derivatives were synthesized as potential anticonvulsant compounds. Mannich compounds…”
    Get full text
    Journal Article